VIVS
VivoSim Labs, INC.
$0.78
-0.12 (-13.00%)
At close · Jul 8
Market Cap
$2.04M
Shares
2,607,962
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.78
Open$0.91
Day$0.78–0.92
52W$0.78–5.30
Avg vol 30d99K
Short int20K · 0.8% float · 1.0d
Short vol50%
Last earningsApr 2, 2025
DataJan 2020–Jul 2026
Filing10-Q · Feb 11
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−60%
below
Price vs 50-day avg
−37%
below
RSI (14)
20
oversold
MACD trend
Negative
52-week position
0%
near low
Momentum
relative strength
1-month return
−34%
trailing
6-month return
−61%
trailing
YTD return
−57%
this year
Relative strength
−68%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
1 of 24 funds reported for Jun 30 · net +200 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.77% of float · ▼ -40.1% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
24 holders — near 1-yr low, contrarian setup
Squeeze score
39
low risk · 0–100
Fundamentals
Revenue growth
+9%
Y/Y
EPS growth
+91%
Y/Y
Free cash flow
$-9.5M
Balance sheet
$11.3M
net cash
Quant / Vol
risk profile
Volatility
124%
annualized · 1-yr
Max drawdown
−84%
past year
ATR
11.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
filed Feb 11, 2026
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−60%
Bearish
Price vs 50-day avg
−37%
Bearish
RSI (14)
20
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
1 of 24 funds reported for Jun 30 · net +200 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.77% of float · ▼ -40.1% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
24 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $1
Now $1 · 0%
52-wk high $5
vs 200-day avg -60%
vs 50-day avg -37%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VIVS
this stock
VivoSim Labs, INC.
|
$2.04M | -56.7% | +8.8% | — | 0.8% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VIVS | -26.8% | -34.2% | -61.0% | -26.8% | -56.7% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -26.6% | -35.0% | -68.5% | -26.6% | -66.1% |